col blocks we are bridge builder col blocks
COVID answers in Scientific Journals all over the world

Silicea - Poligraf, LLC: CARDIOVASCULAR THERAPY AND PREVENTION
  original article Date Title Authors   All Authors
1 [GO] 2021―Jul―18 Thrombectomy vs conservative therapy in patients with COVID-19 A. N. Kazantsev
2 [GO] 2021―Jul―18 COVID-19 and cardiovascular comorbidity: novel approaches to reduce mortality S. S. Bunova, P. I. Okhotnikova, Yu. P. Skirdenko, N. A. Nikolaev, O. A. Osipova, N. I. Zhernakova
3 [GO] 2021―Jul―18 Algorithms for adult outpatient care of coronavirus disease 2019 (COVID-19) and its Assumption M. A. Livzan, O. M. Drapkina, N. A. Nikolaev, Y. P. Skirdenko, R. N. Shepel, I. A. Viktorova, et al. (+15)
4 [GO] 2021―Jul―18 Acute lower limb ischemia in the context of the COVID-19 pandemic I. A. Vinokurov
5 [GO] 2021―Jul―18 Surgical thrombectomy versus conservative treatment in cases of acute limb ischemia with COVID-19 pneumonia A. M. Fahad, H. A. Alkhalidi, Y. Q. M. Altimimi
6 [GO] 2021―Jul―18 Mehman Mamedov: case management during and after coronavirus pandemic Article Editorial
7 [GO] 2021―May―15 COVID-19 from the interdisciplinary standpoint. Round table M. N. Mamedov, Yu. V. Rodionova, I. S. Yavelov, M. I. Smirnova, E. N. Dudinskaya, V. I. Potievskaya
8 [GO] 2021―May―15 Proteolytic enzyme and adiponectin receptors as potential targets for COVID-19 therapy K. A. Rubina, N. R. Sabitova, A. Yu. Efimenko, N. I. Kalinina, J. A. Akopyan, E. V. Semina
9 [GO] 2021―Feb―20 Clinical and laboratory characteristics of patients with COVID-19 and concomitant type 2 diabetes T. Yu. Demidova, K. G. Lobanova, S. N. Perekhodov, M. B. Antsiferov, O. Sh. Oynotkinova
10 [GO] 2020―Dec―31 COVID-19 biobank: features of the cytokine profile N. N. Sushentseva, O. S. Popov, S. V. Apalko, A. Yu. Anisenkova, S. V. Azarenko, K. V. Smantserev, et al. (+8)
11 [GO] 2020―Dec―31 Prospective in-hospital registry of patients with suspected or documented COVID-19 infection and community-acquired pneumonia (TARGET-VIP): characteristics of patients and assessment of in-hospital outcomes O. M. Drapkina, O. E. Karpov, M. M. Lukyanov, S. Yu. Martsevich, A. A. Pulin, N. P. Kutishenko, et al. (+13)
12 [GO] 2020―Dec―31 Work within the COVID-19 pandemic - the experience of the biobank of the National Medical Research Center of Oncology I. V. Samokhina, A. B. Sagakyants
13 [GO] 2020―Jul―03 Debatable points of using angiotensin-converting enzyme inhibitors and angiotensin receptor antagonists in patients with COVID-19 O. M. Drapkina, L. E. Vasilyeva
14 [GO] 2020―Jul―03 COVID-19 and nutrition: new emphases, old priorities (review of guidelines) N. S. Karamnova, O. M. Drapkina
15 [GO] 2020―Jul―03 Health promotion and prevention of chronic non-communicable diseases in the context of the COVID-19 pandemic. Consensus of experts of the National society of evidence-based pharmacotherapy and the Russian society of the prevention of non-communicable diseases O. M. Drapkina, M. G. Gambaryan, B. E. Gorny, N. S. Karamnova, A. V. Kontsevaya, N. K. Novikova, et al. (+3)
16 [GO] 2020―Jul―03 Tobacco smoking and COVID-19: an old enemy in a new guise. Review of current publications M. G. Gambaryan, O. M. Drapkina
17 [GO] 2020―Jul―03 COVID-19: urgent questions for estimating morbidity, prevalence, case fatality rate and mortality rate O. M. Drapkina, I. V. Samorodskaya, M. G. Sivtseva, E. P. Kakorina, N. I. Briko, S. N. Cherkasov, et al. (+2)
18 [GO] 2020―Jul―03 Novel coronavirus infection SARS-CoV-2 in elderly and senile patients: prevention, diagnosis and treatment. Expert Position Paper of the Russian Association of Gerontology and Geriatrics O. N. Tkacheva, Yu. V. Kotovskaya, L. A. Aleksanyan, A. S. Milto, A. V. Naumov, I. D. Strazhesko, et al. (+15)
19 [GO] 2020―Jun―25 Management of patients with comorbidity during novel coronavirus (COVID-19) pandemic. National Consensus Statement 2020 V. B. Grinevich, I. V. Gubonina, V. L. Doshchitsin, Yu. V. Kotovskaya, Yu. A. Kravchuk, V. I. Ped, et al. (+6)
20 [GO] 2020―May―11 Self-monitoring and treatment of chronic non-communicable diseases in the context of the COVID-19 pandemic. Consensus of experts of the National society of evidence-based pharmacotherapy and the Russian society of the prevention of non-communicable diseases S. Yu. Martsevich, N. P. Kutishenko, Yu. V. Lukina, S. N. Tolpygina, L. P. Ivanova, N. A. Dmitrieva, et al. (+2)
21 [GO] 2020―May―11 COVID-19: hemostatic parameters and specifics of antithrombotic treatment I. S. Yavelov, O. M. Drapkina


[de][en]

Last change 2021―Jun―30 20:09:44 UTC

© Daten-Quadrat 2021       Done in 0.016 sec